PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)

Clinical trial NCT04066621 · COMPLETED

Trial details

NCT number: NCT04066621
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Tract Infections Urinary Tract Infections in Children

Start date: 2015-04-28
Primary completion: 2016-06-11
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.